Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MRTX

Mirati Therapeutics

$32.25

-0.1 (-0.31%)

16:19
05/07/18
05/07
16:19
05/07/18
16:19
Hot Stocks
Mirati Therapeutics reports cash and equivalentes $148.7M at March 31 »

Cash, cash equivalents,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$32.25

-0.1 (-0.31%)

16:18
05/07/18
05/07
16:18
05/07/18
16:18
Earnings
Mirati Therapeutics reports Q1 EPS (51c), consensus (61c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CREE

Cree

$39.39

-1 (-2.48%)

, SIX

Six Flags

$59.17

-1.62 (-2.66%)

19:02
04/24/18
04/24
19:02
04/24/18
19:02
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Cree…

CREE

Cree

$39.39

-1 (-2.48%)

SIX

Six Flags

$59.17

-1.62 (-2.66%)

TXN

Texas Instruments

$98.33

0.25 (0.25%)

USNA

USANA

$95.93

0.175 (0.18%)

MKSI

MKS Instruments

$102.85

-3.35 (-3.15%)

SVU

Supervalu

$14.61

-0.02 (-0.14%)

IRBT

iRobot

$59.10

-0.85 (-1.42%)

DDR

DDR Corp.

$6.68

0.025 (0.38%)

IPHI

Inphi

$31.46

1.1 (3.62%)

HA

Hawaiian Holdings

$39.20

-0.3 (-0.76%)

SHPG

Shire

$164.05

3.97 (2.48%)

KN

Knowles

$11.01

-0.575 (-4.97%)

TER

Teradyne

$41.50

1.06 (2.62%)

EW

Edwards Lifesciences

$134.63

-2.59 (-1.89%)

DLB

Dolby

$65.85

-1.4 (-2.08%)

WYNN

Wynn Resorts

$189.70

-3.54 (-1.83%)

COF

Capital One

$97.41

-0.115 (-0.12%)

SGMO

Sangamo

$17.85

-0.3 (-1.65%)

MRTX

Mirati Therapeutics

$28.25

-0.15 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 28

    Apr

  • 02

    May

  • 03

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 15

    May

  • 16

    May

  • 16

    May

  • 29

    May

  • 30

    May

  • 12

    Jun

  • 14

    Aug

  • 21

    Dec

  • 26

    Apr

MRTX

Mirati Therapeutics

$28.25

-0.15 (-0.53%)

16:21
04/24/18
04/24
16:21
04/24/18
16:21
Hot Stocks
Mirati Therapeutics provides update for clinical trial of sitravatinib »

Mirati Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
CLVS

Clovis

$59.60

-2.4 (-3.87%)

, RVNC

Revance

$32.60

-1.5 (-4.40%)

07:44
03/15/18
03/15
07:44
03/15/18
07:44
Conference/Events
Barclays to hold a conference »

Global Healthcare…

CLVS

Clovis

$59.60

-2.4 (-3.87%)

RVNC

Revance

$32.60

-1.5 (-4.40%)

THC

Tenet

$24.42

0.26 (1.08%)

CTMX

CytomX Therapeutics

$34.03

0.99 (3.00%)

UHS

Universal Health

$123.26

-0.63 (-0.51%)

NUVA

NuVasive

$50.67

-0.07 (-0.14%)

PTCT

PTC Therapeutics

$30.39

0.5 (1.67%)

ALKS

Alkermes

$61.50

1.15 (1.91%)

EXAS

Exact Sciences

$52.76

0.21 (0.40%)

IRWD

Ironwood

$15.55

0.09 (0.58%)

OXFD

Oxford Immunotec

$13.01

-0.14 (-1.06%)

SGMO

Sangamo

$25.60

-0.4 (-1.54%)

MMSI

Merit Medical

$46.85

-0.45 (-0.95%)

FOLD

Amicus

$15.17

0.01 (0.07%)

MRTX

Mirati Therapeutics

$34.25

0.35 (1.03%)

PTGX

Protagonist Therapeutics

$20.41

-0.26 (-1.26%)

BLUE

Bluebird Bio

$220.20

-3.15 (-1.41%)

NBIX

Neurocrine

$92.30

1.94 (2.15%)

LIFE

aTyr Pharma

$3.00

0.05 (1.69%)

QURE

uniQure

$22.36

-2.75 (-10.95%)

ALNY

Alnylam

$141.83

-2.33 (-1.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

  • 20

    Mar

  • 20

    Mar

  • 29

    Mar

  • 05

    Apr

  • 06

    Apr

  • 17

    Apr

  • 03

    May

  • 30

    May

  • 11

    Aug

  • 13

    Aug

  • 12

    Sep

MRTX

Mirati Therapeutics

$34.60

3.65 (11.79%)

07:15
03/12/18
03/12
07:15
03/12/18
07:15
Recommendations
Mirati Therapeutics analyst commentary at H.C. Wainwright »

Mirati Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 13

    Mar

  • 20

    Mar

  • 20

    Mar

MRTX

Mirati Therapeutics

$34.60

3.65 (11.79%)

04:48
03/12/18
03/12
04:48
03/12/18
04:48
Initiation
Mirati Therapeutics initiated at Barclays »

Mirati Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 13

    Mar

  • 20

    Mar

  • 20

    Mar

MRTX

Mirati Therapeutics

$30.95

0.2 (0.65%)

09:30
03/09/18
03/09
09:30
03/09/18
09:30
Recommendations
Mirati Therapeutics analyst commentary at SunTrust »

Mirati Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

MRTX

Mirati Therapeutics

$30.95

0.2 (0.65%)

16:33
03/08/18
03/08
16:33
03/08/18
16:33
Earnings
Breaking Earnings news story on Mirati Therapeutics »

Mirati Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

MRTX

Mirati Therapeutics

$28.45

0.8 (2.89%)

08:42
03/05/18
03/05
08:42
03/05/18
08:42
Recommendations
Mirati Therapeutics analyst commentary at Citi »

Mirati Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.